Is Roux-en-Y Gastric Bypass Adequate in the Super-Obese?

Sánchez-Santos, Raquel; Vilarrasa, Núria; Pujol, Jorge; Moreno, Pablo; Francos, José Manuel; Rafecas, A; Masdevall, Carlos

doi:10.1381/096089206776327224

Cited by 24 publications

(13 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Surgical treatment of obesity has been shown to be the only consistent option for sustained, reproducible weight loss, and many comorbidities associated with morbid obesity such as arthritis, hypertension, diabetes, and sleep apnea are significantly alleviated or cured after LapRNYGB [2,[9][10][11]. On the other hand, the super-superobese patient generally has more comorbidities as compared with the superobese patient [9,12]. In addition, the super-superobese body habitus has technical implications which may make the operation more difficult: hepatic steatosis, a thickened transverse mesocolon, and ample visceral fat.…”

Section: Discussionmentioning

confidence: 99%

Is BMI greater than 60 kg/m2 a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?

et al. 2009

View full text Add to dashboard Cite

Patients with BMI >or= 60 kg/m(2) do not have a higher postoperative morbidity compared with other patients undergoing laparoscopic Roux-en-Y gastric bypass. The stricture rate is less in patients with BMI >or= 60 kg/m(2) compared with other patients. Longer follow-up is required to detect complications that occur after 1 year. Our study shows that laparoscopic Roux-en-Y gastric bypass can be safely performed on the super-supermorbidly obese.

show abstract

Section: Discussionmentioning

confidence: 99%

Is BMI greater than 60 kg/m2 a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Moreover, recent studies have shown that SG provides effective weight loss outcomes without the second malabsorptive step that occurs with the duodenal switch [11][12][13][14]. In a similar way, isolated single step RYGB has also shown positive weight loss outcomes in super obese patients [9,15]. Overall, additional data are needed to examine postsurgical outcomes as well as to formulate recommendations regarding the surgical care of super-super obese patients.…”

Section: Introductionmentioning

confidence: 99%

Surgical management of super–super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy

et al. 2015

View full text Add to dashboard Cite

show abstract

“…In terms of weight loss, the overall mean percentage of EWL in patients who underwent RYGB varies, as published in a meta-analysis by Buchwald and other publications, between 68 and 87.5% with follow-up periods between 1.6 and 5 years [14,15,16]. Consequently, the aim for EWL after RYGB surgery should be 70-80%.…”

Section: Resultsmentioning

confidence: 99%

“…Since the proximal gastric bypass shows a failure rate of approximately 20%, some surgeons increased the length of the alimentary (Roux) limb especially in superobese patients [15]. However, the so-called distal bypass, which is characterized by long alimentary (Roux) limb and a relatively short common channel, puts the patient at potential risk of severe alimentary deficiencies and anemia.…”

Section: Resultsmentioning

confidence: 99%

Gastric Bypass: Current Results and Different Techniques

Vines¹,

Schiesser²

2014

Dig Surg

View full text Add to dashboard Cite

Obesity has been steadily increasing over the last three decades and is one of the leading causes of increased health costs due to its associated comorbidities. Unfortunately, conservative treatment including lifestyle changes did not achieve the desired results. Bariatric surgery, on the other hand, has emerged as an effective and safe treatment for obesity and its related comorbidities such as type 2 diabetes. Much time has passed since the first Roux-en-Y gastric bypass was performed in the 1960s, and the operation technique has since evolved. New variations such as the distal gastric bypass as well as the omega loop bypass have been developed. Today, the laparoscopic gastric bypass is still the most widely applied bariatric operation technique, followed by laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. The refinement of the surgical technique and the introduction of laparoscopy have resulted in low perioperative morbidity and mortality after gastric bypass surgery. In this article, we will be discussing the history of gastric bypass surgery as well as presenting current data on excessive weight loss and resolution of comorbidities with a focus on diabetes. We will be looking into newer techniques such as omega loop bypass and their efficacy compared to the standard gastric bypass. Furthermore, we will be addressing the most important early and long-term complications, their diagnostic strategies as well as their management.

show abstract

Is Roux-en-Y Gastric Bypass Adequate in the Super-Obese?

Abstract: RYGBP achieved significant durable weight loss and effectively treated co-morbid conditions in SO and SSO patients with acceptable postoperative morbidity and slightly greater mortality than in MO patients.

Cited by 24 publications

References 28 publications

Is BMI greater than 60 kg/m2 a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?

Is BMI greater than 60 kg/m2 a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?

Surgical management of super–super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy

Gastric Bypass: Current Results and Different Techniques

Contact Info

Product

Resources

About